CTSO - Company ID 0001175151
The table below shows Cytosorbents Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.41M | $4.81M | $7.54M | $10.20M | $11.59M | $5.69M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $6.79M | $7.15M | $7.43M | $7.74M | $7.67M | $6.63M |
| Inventory | $3.69M | $4.48M | $4.00M | $3.71M | $3.02M | $3.25M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $15.74M |
| $17.76M |
| $21.31M |
| $22.99M |
| $25.41M |
| $16.60M |
| Property, plant & equipment | $7.17M | $7.51M | $8.19M | $8.47M | $8.72M | $9.27M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $37.96M | $40.56M | $45.75M | $47.99M | $50.78M | $47.80M |
| Accounts payable | $2.00M | $3.13M | $3.04M | $3.39M | $3.33M | $2.34M |
| Total current liabilities | $24.02M | $16.30M | $10.11M | $9.84M | $9.74M | $8.43M |
| Long-term debt | $3.09M | $10.31M | $14.57M | $14.38M | $14.19M | $13.81M |
| Total liabilities | $38.71M | $38.37M | $36.73M | $36.40M | $36.24M | $34.80M |
| Retained earnings | -$321.75M | -$317.34M | -$306.71M | -$303.54M | -$305.49M | -$295.34M |
| Total equity | -$751.00K | $2.19M | $9.02M | $11.59M | $14.54M | $13.00M |